August 26, 2016
The Ministry of Health, Labor and Welfare (MHLW) said on August 24 that it has granted orphan drug designation for Pfizer’s lung cancer drug crizotinib and three other drugs. Crizotinib was granted the status for the indication of ROS1 fusion...read more